187 related articles for article (PubMed ID: 31865407)
1.
Grkovski M; Kohutek ZA; Schöder H; Brennan CW; Tabar VS; Gutin PH; Zhang Z; Young RJ; Beattie BJ; Zanzonico PB; Huse JT; Rosenblum MK; Blasberg RG; Humm JL; Beal K
Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1446-1457. PubMed ID: 31865407
[TBL] [Abstract][Full Text] [Related]
2. Editorial commentary to "
Lovinfosse P; Ben Mustapha S; Withofs N
Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1340-1341. PubMed ID: 31872279
[No Abstract] [Full Text] [Related]
3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
4. Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible?
Tsuyuguchi N; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Takami T; Otsuka Y; Sakamoto S; Ohata K; Goto T; Hara M
J Neurosurg; 2003 May; 98(5):1056-64. PubMed ID: 12744366
[TBL] [Abstract][Full Text] [Related]
5. Prognosis Related to Metastatic Burden Measured by ¹⁸F-Fluorocholine PET/CT in Castration-Resistant Prostate Cancer.
Kwee SA; Lim J; Watanabe A; Kromer-Baker K; Coel MN
J Nucl Med; 2014 Jun; 55(6):905-10. PubMed ID: 24676753
[TBL] [Abstract][Full Text] [Related]
6.
Grkovski M; Gharzeddine K; Sawan P; Schöder H; Michaud L; Weber WA; Humm JL
J Nucl Med; 2018 Nov; 59(11):1672-1678. PubMed ID: 29626123
[TBL] [Abstract][Full Text] [Related]
7. Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery--in malignant glioma.
Tsuyuguchi N; Takami T; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Nishikawa M; Ohata K; Torii K; Morino M; Nishio A; Hara M
Ann Nucl Med; 2004 Jun; 18(4):291-6. PubMed ID: 15359921
[TBL] [Abstract][Full Text] [Related]
8. Long-term metabolic evolution of brain metastases with suspected radiation necrosis following stereotactic radiosurgery: longitudinal assessment by F-DOPA PET.
Cicone F; Carideo L; Scaringi C; Romano A; Mamede M; Papa A; Tofani A; Cascini GL; Bozzao A; Scopinaro F; Minniti G
Neuro Oncol; 2021 Jun; 23(6):1024-1034. PubMed ID: 33095884
[TBL] [Abstract][Full Text] [Related]
9. Quantitative
Schaefferkoetter JD; Wang Z; Stephenson MC; Roy S; Conti M; Eriksson L; Townsend DW; Thamboo T; Chiong E
EJNMMI Res; 2017 Dec; 7(1):25. PubMed ID: 28324340
[TBL] [Abstract][Full Text] [Related]
10. Quantification of 18F-fluorocholine kinetics in patients with prostate cancer.
Verwer EE; Oprea-Lager DE; van den Eertwegh AJ; van Moorselaar RJ; Windhorst AD; Schwarte LA; Hendrikse NH; Schuit RC; Hoekstra OS; Lammertsma AA; Boellaard R
J Nucl Med; 2015 Mar; 56(3):365-71. PubMed ID: 25678491
[TBL] [Abstract][Full Text] [Related]
11. Baseline and Post-treatment 18F-Fluorocholine PET/CT Predicts Outcomes in Hepatocellular Carcinoma Following Locoregional Therapy.
Wallace MC; Sek K; Francis RJ; Samuelson S; Ferguson J; Tibballs J; Asad A; Preen DB; MacQuillan G; Garas G; Adams LA; Jeffrey GP
Dig Dis Sci; 2020 Feb; 65(2):647-657. PubMed ID: 31440998
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of [
Cysouw M; Bouman-Wammes E; Hoekstra O; van den Eertwegh A; Piet M; van Moorselaar J; Boellaard R; Dahele M; Oprea-Lager D
Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):406-410. PubMed ID: 29559285
[TBL] [Abstract][Full Text] [Related]
13. [Single center experience of (18F)-fluorocholine positron emission tomography: analysis of its impact on salvage local therapy in patients with prostate adenocarcinoma].
Moussaid Y; Bonardel G; Jacob J; Métivier D; Gontier E; Bauduceau O; Durand X; Fayolle M; Houlgatte A; Foehrenbach H; Védrine L; Chargari C
Cancer Radiother; 2013; 17(4):259-64. PubMed ID: 23702489
[TBL] [Abstract][Full Text] [Related]
14. Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas.
Fueger BJ; Czernin J; Cloughesy T; Silverman DH; Geist CL; Walter MA; Schiepers C; Nghiemphu P; Lai A; Phelps ME; Chen W
J Nucl Med; 2010 Oct; 51(10):1532-8. PubMed ID: 20847166
[TBL] [Abstract][Full Text] [Related]
15. Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET.
Kwee SA; Wei H; Sesterhenn I; Yun D; Coel MN
J Nucl Med; 2006 Feb; 47(2):262-9. PubMed ID: 16455632
[TBL] [Abstract][Full Text] [Related]
16. Dynamic
Lim W; Acker G; Hardt J; Kufeld M; Kluge A; Brenner W; Conti A; Budach V; Vajkoczy P; Senger C; Prasad V
Cancer Treat Res Commun; 2022; 32():100583. PubMed ID: 35688103
[TBL] [Abstract][Full Text] [Related]
17. FDG PET/MRI Coregistration Helps Predict Response to Gamma Knife Radiosurgery in Patients With Brain Metastases.
Leiva-Salinas C; Muttikkal TJE; Flors L; Puig J; Wintermark M; Patrie JT; Rehm PK; Sheehan JP; Schiff D
AJR Am J Roentgenol; 2019 Feb; 212(2):425-430. PubMed ID: 30422717
[TBL] [Abstract][Full Text] [Related]
18. Solitary brain lesions enhancing at MR imaging: evaluation with fluorine 18 fluorocholine PET.
Kwee SA; Ko JP; Jiang CS; Watters MR; Coel MN
Radiology; 2007 Aug; 244(2):557-65. PubMed ID: 17581887
[TBL] [Abstract][Full Text] [Related]
19. Performance of quantitative measurements in [
Jacquet-Francillon N; Morelec I; Germain N; Prades JM; Habouzit V; Mariat C; Bonnefoy PB; Prevot N
Front Med (Lausanne); 2022; 9():956580. PubMed ID: 35983092
[TBL] [Abstract][Full Text] [Related]
20.
Beheshti M; Hehenwarter L; Paymani Z; Rendl G; Imamovic L; Rettenbacher R; Tsybrovskyy O; Langsteger W; Pirich C
Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1762-1771. PubMed ID: 29516131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
